JP2006502228A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006502228A5 JP2006502228A5 JP2004543559A JP2004543559A JP2006502228A5 JP 2006502228 A5 JP2006502228 A5 JP 2006502228A5 JP 2004543559 A JP2004543559 A JP 2004543559A JP 2004543559 A JP2004543559 A JP 2004543559A JP 2006502228 A5 JP2006502228 A5 JP 2006502228A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine composition
- hiv
- composition according
- plg
- dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 43
- 229940033330 HIV vaccine Drugs 0.000 claims 21
- 229960005486 vaccine Drugs 0.000 claims 18
- 108020004707 nucleic acids Proteins 0.000 claims 7
- 102000039446 nucleic acids Human genes 0.000 claims 7
- 150000007523 nucleic acids Chemical class 0.000 claims 7
- 108010041986 DNA Vaccines Proteins 0.000 claims 5
- 229940021995 DNA vaccine Drugs 0.000 claims 5
- 108020004414 DNA Proteins 0.000 claims 4
- 239000002671 adjuvant Substances 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 239000013604 expression vector Substances 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 108091026890 Coding region Proteins 0.000 claims 2
- 238000007918 intramuscular administration Methods 0.000 claims 2
- 239000011859 microparticle Substances 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 238000012258 culturing Methods 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 239000006228 supernatant Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41657302P | 2002-10-07 | 2002-10-07 | |
| PCT/US2003/031935 WO2004032860A2 (en) | 2002-10-07 | 2003-10-07 | Hiv vaccine formulations |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011226126A Division JP2012012416A (ja) | 2002-10-07 | 2011-10-13 | Ｈｉｖワクチン処方物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006502228A JP2006502228A (ja) | 2006-01-19 |
| JP2006502228A5 true JP2006502228A5 (enExample) | 2006-11-24 |
Family
ID=32093869
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004543559A Pending JP2006502228A (ja) | 2002-10-07 | 2003-10-07 | Ｈｉｖワクチン処方物 |
| JP2011226126A Pending JP2012012416A (ja) | 2002-10-07 | 2011-10-13 | Ｈｉｖワクチン処方物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011226126A Pending JP2012012416A (ja) | 2002-10-07 | 2011-10-13 | Ｈｉｖワクチン処方物 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US20060110736A1 (enExample) |
| EP (1) | EP1565583A4 (enExample) |
| JP (2) | JP2006502228A (enExample) |
| AU (1) | AU2003282498A1 (enExample) |
| CA (2) | CA2823937A1 (enExample) |
| WO (1) | WO2004032860A2 (enExample) |
| ZA (1) | ZA200503554B (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005204385A1 (en) * | 2004-01-07 | 2005-07-28 | Biomedical Research Models, Inc. | Methods for tailoring the immune response to an antigen or immunogen |
| US8399423B2 (en) * | 2005-10-12 | 2013-03-19 | Idera Pharmaceuticals, Inc. | Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response |
| CA2605135C (en) | 2006-10-17 | 2014-12-30 | Tyco Healthcare Group Lp | Apparatus for applying surgical clips |
| US20120258540A1 (en) * | 2006-11-13 | 2012-10-11 | Georgia Tech Research Corporation | Methods for modifying virus surfaces |
| SI2200642T1 (sl) * | 2007-10-19 | 2012-06-29 | Novartis Ag | Formulacije meningokoknega cepiva |
| US20110208212A1 (en) * | 2010-02-19 | 2011-08-25 | Zergiebel Earl M | Surgical clip applier |
| US9358015B2 (en) | 2008-08-29 | 2016-06-07 | Covidien Lp | Endoscopic surgical clip applier with wedge plate |
| US8403945B2 (en) | 2010-02-25 | 2013-03-26 | Covidien Lp | Articulating endoscopic surgical clip applier |
| US8932575B2 (en) | 2010-09-21 | 2015-01-13 | University Of Miami | Compositions and methods for inducing migration by dendritic cells and an immune response |
| WO2012040266A2 (en) * | 2010-09-24 | 2012-03-29 | University Of Miami | Gene-based adjuvants and compositions thereof to increase antibody production in response to gene-based vaccines |
| US9011464B2 (en) | 2010-11-02 | 2015-04-21 | Covidien Lp | Self-centering clip and jaw |
| US9186153B2 (en) | 2011-01-31 | 2015-11-17 | Covidien Lp | Locking cam driver and jaw assembly for clip applier |
| US9532787B2 (en) | 2012-05-31 | 2017-01-03 | Covidien Lp | Endoscopic clip applier |
| ES2847930T3 (es) | 2013-01-07 | 2021-08-04 | Mucosal Vaccine Tech Llc | Vacunas terapéuticas para el tratamiento de las infecciones por el virus del herpes simple de tipo 2 |
| US10188749B2 (en) | 2016-04-14 | 2019-01-29 | Fred Hutchinson Cancer Research Center | Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers |
| JP7348063B2 (ja) | 2017-01-05 | 2023-09-20 | フレッド ハッチンソン キャンサー センター | ワクチン効力を改善するためのシステム及び方法 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5036006A (en) | 1984-11-13 | 1991-07-30 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
| US5100792A (en) | 1984-11-13 | 1992-03-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues |
| US4945050A (en) | 1984-11-13 | 1990-07-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
| US4663161A (en) | 1985-04-22 | 1987-05-05 | Mannino Raphael J | Liposome methods and compositions |
| US4871488A (en) | 1985-04-22 | 1989-10-03 | Albany Medical College Of Union University | Reconstituting viral glycoproteins into large phospholipid vesicles |
| HU212924B (en) | 1989-05-25 | 1996-12-30 | Chiron Corp | Adjuvant formulation comprising a submicron oil droplet emulsion |
| US5603960A (en) * | 1993-05-25 | 1997-02-18 | O'hagan; Derek T. | Preparation of microparticles and method of immunization |
| US6015686A (en) | 1993-09-15 | 2000-01-18 | Chiron Viagene, Inc. | Eukaryotic layered vector initiation systems |
| US5643605A (en) * | 1993-10-25 | 1997-07-01 | Genentech, Inc. | Methods and compositions for microencapsulation of adjuvants |
| US6171596B1 (en) * | 1993-12-10 | 2001-01-09 | The United States Of America As Represented By The Department Of Health And Human Services | Oligomeric HIV-1 envelope glycoproteins |
| US20030050263A1 (en) * | 1994-07-15 | 2003-03-13 | The University Of Iowa Research Foundation | Methods and products for treating HIV infection |
| DK0991403T3 (da) * | 1997-01-30 | 2003-07-28 | Chiron Corp | Anvendelse af mikropartikler med adsorberet antigen til stimulering af immunresponser |
| US6884435B1 (en) * | 1997-01-30 | 2005-04-26 | Chiron Corporation | Microparticles with adsorbent surfaces, methods of making same, and uses thereof |
| US6099847A (en) * | 1997-05-15 | 2000-08-08 | The United States Of America As Represented By The Department Of Health And Human Services | Chimeric Gag pseudovirions |
| US7393630B2 (en) * | 1997-12-16 | 2008-07-01 | Novartis Vaccines And Diagnostics, Inc. | Use of microparticles combined with submicron oil-in-water emulsions |
| PT1042001E (pt) * | 1997-12-16 | 2002-09-30 | Chiron Corp | Uso de microparticulas combinadas com emulsoes submicronicas oleo-em-agua |
| FR2775188B1 (fr) * | 1998-02-23 | 2001-03-09 | Lipha | Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption |
| NZ509853A (en) | 1998-07-29 | 2003-08-29 | Chiron Corp | Microparticles with an adsorbent surface useful for delivering pharmaceuticals |
| AU2487300A (en) | 1998-12-31 | 2000-07-31 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| US6602705B1 (en) | 1998-12-31 | 2003-08-05 | Chiron Corporation | Expression of HIV polypeptides and production of virus-like particles |
| CA2358915C (en) | 1998-12-31 | 2010-06-01 | Chiron Corporation | Modified hiv env polypeptides |
| US7935805B1 (en) | 1998-12-31 | 2011-05-03 | Novartis Vaccines & Diagnostics, Inc | Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof |
| AUPQ520800A0 (en) * | 2000-01-21 | 2000-02-17 | Alfred Hospital | Prime-boost vaccination strategy |
| US20040022814A1 (en) * | 2000-06-15 | 2004-02-05 | O'hagan Derek | Microparticles with adsorbent surfaces, methods of making same, and uses thereof |
| US6753015B2 (en) * | 2000-09-28 | 2004-06-22 | Chiron Corporation | Microparticle compositions and methods for the manufacture thereof |
| JP2004518631A (ja) * | 2000-09-28 | 2004-06-24 | カイロン コーポレイション | 異種核酸の送達のための微粒子 |
| AU2001297896A1 (en) * | 2000-12-08 | 2003-01-02 | Medimmune, Inc. | Mutant proteins, high potency inhibitory antibodies and fimch crystal structure |
| CA2634992C (en) * | 2001-07-05 | 2012-10-16 | Novartis Vaccines And Diagnostics, Inc. | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| EP1409694A4 (en) * | 2001-07-05 | 2006-02-08 | Chiron Corp | POLYNUCLEOTIDES ENCODING ANTIGENIC POLYPEPTIDES OF HIV SUBTYPE B AND / OR SUBTYPE C, POLYPEPTIDES AND USES THEREOF |
| WO2003020876A2 (en) * | 2001-08-31 | 2003-03-13 | Chiron Corporation | Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
| US20030170614A1 (en) * | 2001-08-31 | 2003-09-11 | Megede Jan Zur | Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof |
| CA2513418C (en) * | 2003-01-14 | 2016-04-19 | Chiron Corporation | Microparticles with adsorbed polynucleotide-containing species |
| CN101784338B (zh) | 2007-07-06 | 2013-10-30 | M技术株式会社 | 携载金属的碳的制造方法 |
-
2003
- 2003-10-07 US US10/530,543 patent/US20060110736A1/en not_active Abandoned
- 2003-10-07 CA CA2823937A patent/CA2823937A1/en not_active Abandoned
- 2003-10-07 EP EP03774690A patent/EP1565583A4/en not_active Withdrawn
- 2003-10-07 AU AU2003282498A patent/AU2003282498A1/en not_active Abandoned
- 2003-10-07 CA CA002501476A patent/CA2501476A1/en not_active Abandoned
- 2003-10-07 WO PCT/US2003/031935 patent/WO2004032860A2/en not_active Ceased
- 2003-10-07 JP JP2004543559A patent/JP2006502228A/ja active Pending
-
2005
- 2005-05-04 ZA ZA200503554A patent/ZA200503554B/en unknown
-
2009
- 2009-02-02 US US12/364,294 patent/US20090238841A1/en not_active Abandoned
-
2011
- 2011-10-13 JP JP2011226126A patent/JP2012012416A/ja active Pending
- 2011-12-22 US US13/334,739 patent/US8609109B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kayraklioglu et al. | CpG oligonucleotides as vaccine adjuvants | |
| Taslimi et al. | Leishmaniasis and various immunotherapeutic approaches | |
| US10273269B2 (en) | High potency immunogenic zika virus compositions | |
| Halperin et al. | Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18–55 years of age | |
| Salonius et al. | The road to licensure of a DNA vaccine | |
| JP2006502228A5 (enExample) | ||
| Higgins et al. | Immunostimulatory DNA as a vaccine adjuvant | |
| Tomai et al. | TLR7/8 agonists as vaccine adjuvants | |
| JP2007523863A5 (enExample) | ||
| JP2010519205A5 (enExample) | ||
| RU2006106848A (ru) | Улучшения в вакцинации | |
| JP2011026328A (ja) | オリゴヌクレオチド組成物および免疫応答の調節のためのそれらの使用 | |
| JP2001526688A (ja) | オリゴヌクレオチドアジュバント | |
| Zhang et al. | Effects of astragalus polysaccharide on the immune response to foot-and-mouth disease vaccine in mice | |
| TW200307557A (en) | Stabilized synthetic immunogen delivery systems | |
| JP2006020648A5 (enExample) | ||
| MX2011012147A (es) | Inmunoterapia de vacuna. | |
| JP2008000001A (ja) | 免疫刺激オリゴヌクレオチドおよびその医薬用途 | |
| Xiang et al. | Promising particle-based vaccines in cancer therapy | |
| CN110612118A (zh) | 用于引起针对hbv的免疫应答的病毒样粒子 | |
| JP2023506439A (ja) | 医薬組成物及びその用途 | |
| CN100425287C (zh) | 肿瘤疫苗 | |
| US8734806B2 (en) | Immunogenic composition and use thereof | |
| JP2003530088A5 (enExample) | ||
| Stephen et al. | Swine influenza virus vaccine: potentiation of antibody responses in rhesus monkeys |